close

Enter

Log in using OpenID

embedDownload
本ガイドラインの専門委員会−名簿
HHS Panel on Antiretroviral Guidelines
for Adults and Adolescents Panel Roster
本ガイドラインは、HHS(Department of Health and Human Service:米国保健福祉省)の「成人および
青少年に対する抗レトロウイルス薬に関するガイドライン専門委員会(Office of AIDS Research
Advisory Council の作業委員会のひとつ)」によって作成されたものである。
●共同座長
John G. Bartlett Roy M. Gulick
Martin S. Hirsch
H. Clifford Lane ●事務局長
Alice K. Pau
●メンバー
Judith Aberg Adaora Adimora
John T. Brooks J. Kevin Carmichael Deborah L. Cohan Eric Daar Steven G. Deeks Carlos del Rio
Gerald Friedland Joel E. Gallant Rajesh T. Gandhi Stephen J. Gange
Thomas Giordano
Richard Haubrich W. Keith Henry Michael D. Hughes
Peter Hunt Bill G. Kapogiannis
Marla Keller
Daniel R. Kuritzkes
Jeffrey Lennox Richard W. Price
James L. Raper Bret J. Rudy Michael Saag
Paul Sax
Kimberly Scarsi Mark Sulkowski
Pablo Tebas
Zelalem Temesgen Phyllis Tien Rochelle Walensky David A. Wohl
●地域社会団体に属するメンバー
Lei Chou Paul Dalton David Evans Danielle Houston
Jeff Taylor Nelson Vergel x
Johns Hopkins University, Baltimore, MD(2013 年 12 月 31 日、任期終了)
Weill Medical College of Cornell University, New York, NY(2014 年 1 月 1 日、任期開始)
Massachusetts General Hospital & Harvard Medical School, Boston, MA
(2014 年 1 月 1 日、任期開始)
National Institutes of Health, Bethesda, MD
National Institutes of Health, Bethesda, MD
Icahn School of Medicine of Mount Sinai University, New York, NY
University of North Carolina, Chapel Hill, NC
Centers for Disease Control and Prevention, Atlanta, GA
El Rio Specialty Immunology Associates, Tucson, AZ
University of California–San Francisco, San Francisco, CA
University of California–Los Angeles, Harbor-UCLA Medical Center, Los Angeles, CA
University of California–San Francisco, San Francisco, CA(2014 年 3 月 4 日、任期終了)
Emory University, Atlanta, GA(2014 年 3 月 4 日、任期終了)
Yale University School of Medicine, New Haven, CT
Southwest CARE Center, Santa Fe, NM(2014 年 3 月 4 日、任期終了)
Massachusetts General Hospital & Harvard Medical School, Boston, MA
Johns Hopkins University, Baltimore, MD
Baylor College of Medicine, Houston, TX(2014 年 3 月 4 日、任期開始)
University of California–San Diego, San Diego, CA(2014 年 3 月 4 日、任期開始)
Hennepin County Medical Center & University of Minnesota, Minneapolis, MN
(2014 年 3 月 4 日、任期終了)
Harvard School of Public Health, Boston, MA
University of California–San Francisco, San Francisco, CA(2014 年 3 月 4 日、任期開始)
National Institutes of Health, Bethesda, MD
Albert Einstein College of Medicine, New York, NY(2014 年 3 月 4 日、任期開始)
Brigham and Women’s Hospital & Harvard Medical School, Boston, MA
Emory University, Atlanta, GA(2014 年 3 月 4 日、任期開始)
University of California–San Francisco, San Francisco, CA
University of Alabama at Birmingham, Birmingham, AL
New York University, New York, NY
University of Alabama at Birmingham, Birmingham, AL(2014 年 3 月 4 日、任期終了)
Brigham and Women’s Hospital & Harvard Medical School, Boston, MA
University of Nebraska, Omaha, NE
Johns Hopkins University, Baltimore, MD
University of Pennsylvania, Philadelphia, PA
Mayo Clinic, Rochester, MN
University of California–San Francisco, San Francisco, CA
Massachusetts General Hospital & Harvard Medical School, Boston, MA
University of North Carolina, Chapel Hill, NC
Treatment Action Group, New York, NY
San Francisco, CA(2014 年 3 月 4 日、任期終了)
Project Inform, San Francisco, CA
Houston, TX
AIDS Treatment Activists Coalition, Palm Springs, CA
Program for Wellness Restoration, Houston, TX
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
本ガイドラインの専門委員会−名簿
● HHS からの代表メンバー
Victoria Cargill Laura Cheever Jonathan Kaplan Kendall Marcus Henry Masur Lynne Mofenson Kimberly Struble National Institutes of Health, Rockville, MD
Health Resources and Services Administration, Rockville, MD
Centers for Disease Control and Prevention, Atlanta, GA
Food and Drug Administration, Silver Spring, MD
National Institutes of Health, Bethesda, MD
National Institutes of Health, Bethesda, MD
Food and Drug Administration, Silver Spring, MD
●謝辞
今回、薬物相互作用の表の改訂に助力してくださった Sarita D. Boyd、Monica Calderon(Food and Drug Administration)
、Lori
Gordon(National Institutes of Health)
、および「治療未経験患者に対する抗レトロウイルス療法の開始」項目中の「悪性腫瘍」の検討
に貢献してくださった Thomas Uldrick(National Cancer Institute)に感謝の意を表する。
2014 年 5 月 1 日改訂、2014 年 5 月 1 日見直し
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
xi
Author
Document
Category
Uncategorized
Views
2
File Size
660 KB
Tags
1/--pages
Report inappropriate content